TMF and glycitin act synergistically on keratinocytes and fibroblasts to promote wound healing and anti-scarring activity.
- Author:
Ga Young SEO
1
;
Yoongho LIM
;
Dongsoo KOH
;
Jung Sik HUH
;
Changlim HYUN
;
Young Mee KIM
;
Moonjae CHO
Author Information
- Publication Type:Original Article
- MeSH: Animals; Burns; Cicatrix; Coculture Techniques; Fibroblasts*; In Vitro Techniques; Isoflavones; Keratinocytes*; Mice; Models, Animal; Regeneration; Skin; Wound Healing*; Wounds and Injuries*
- From:Experimental & Molecular Medicine 2017;49(3):e302-
- CountryRepublic of Korea
- Language:English
- Abstract: Keratinocyte-fibroblast interactions are critical for skin repair after injury. During the proliferative phase of wound healing, proliferation, migration and differentiation of these cells are the major mechanisms leading to tissue remodeling. We have previously reported that glycitin, a major soy isoflavone, stimulates dermal fibroblast proliferation; and the phytochemical, 4′,6,7-trimethoxyisoflavone (TMF), induces migration of HaCaT keratinocyte cells. We therefore investigated whether these compounds display synergistic effects on skin cells during wound healing in vitro and in vivo. Co-treatment with TMF and glycitin synergistically promotes the proliferation and migration of both keratinocytes and dermal fibroblasts, with a 1:1 ratio of these compounds showing the greatest efficacy in our co-culture system. This keratinocyte-fibroblast interaction occurred via the secretion of TGF-β, and the induction of differentiation and proliferation was confirmed in both indirect and direct co-culture assays. In an excisional and burn wound animal model, mice treated with a 1:1 ratio of TMF and glycitin showed faster wound closure, regeneration and scar reduction than even the positive control drug. These data indicate that two isoflavones, TMF and glycitin, act synergistically to promote wound healing and anti-scarring and could potentially be developed together as a bioactive therapeutic for wound treatment.
